Ausgabe 6/2022
Inhalt (14 Artikel)
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
- Open Access
- Chronic Myeloid Leukemias (V Oehler, Section Editor)
Nur Hezrin Shahrin, Carol Wadham, Susan Branford
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies
- Chronic Myeloid Leukemias (V Oehler, Section Editor)
John Joson Ng, S. Tiong Ong
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions
- Chronic Myeloid Leukemias (V Oehler, Section Editor)
Emilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia
Value in Myeloma Care: Myth or Reality
- Health Economics (N Khera, Section Editor)
Evguenia Ouchveridze, Katherine Berger, Ghulam Rehman Mohyuddin
Precision Medicine in Myeloid Malignancies: Hype or Hope?
- Health Economics (N Khera, Section Editor)
Shristi Upadhyay Banskota, Nabin Khanal, Rosalyn I. Marar, Prajwal Dhakal, Vijaya Raj Bhatt
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
- Health Economics (N Khera, Section Editor)
Neel S. Bhatt
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults
- Open Access
- Health Economics (R Mesa)
Ginna Granroth, Nandita Khera, Cecilia Arana Yi
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms
- Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)
Anmol Baranwal, Christopher N. Hahn, Mithun Vinod Shah, Devendra K. Hiwase
Pediatric Germline Predisposition to Myeloid Neoplasms
- Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)
Christineil Thompson, Sydney Ariagno, Mira A. Kohorst
Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies
- Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)
Himachandana Atluri, Yoheved S. Gerstein, Courtney D. DiNardo
Bispecific Antibodies for the Treatment of Multiple Myeloma
- T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
Scott R. Goldsmith, Shawn Streeter, Fahrettin Covut
Circulating Tumor DNA in Lymphoma
- T-Cell and Other Lymphoproliferative Malignancies (R Mesa, Section Editor)
Swetha Kambhampati Thiruvengadam, Jasmine Zain
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
- Multiple Myeloma (Prashant Kapoor, Section Editor)
Arleigh McCurdy, Alissa Visram
Molecular Pathogenesis of Myeloproliferative Neoplasms
- Myeloproliferative Neoplasms (P Bose, Section Editor)
Benjamin Rolles, Ann Mullally